The Latest Healthcare Services Articles from Streetwise Reports

US Biotech Firm Keeps Growing Revenue

Research Report
  ()
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report.

Co. Pursuing Ketamine for Addiction Forms Partnership

Research Report
  ()
In landing this first licensing deal, the life sciences firm "shows good progress towards a potentially high-margin business," noted a Stifel report.

Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’

Research Report
  ()
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with Alcohol Use Disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD.

Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry

Research Report
  ()
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report.

Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co.

Research Report
  ()
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments.

Healthcare Tech Firm Improves Earnings and Cash Flow in Q3/22

Research Report
  ()
These changes earned Reliq Health Technologies Inc. an upgrade in overall rating by independent investment research and advisory firm, Jefferson Research.

Showing Results: 1 to 6 of 6